Mnemosyne Pharmaceuticals' Series A - II Round

Mnemosyne Pharmaceuticals raised a round of funding on July 02, 2013. Investors include Atlas Venture.

Mnemosyne Pharmaceuticals is a drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders. The company is exploring …

Articles about Mnemosyne Pharmaceuticals' Series A - II Round: